Related references
Note: Only part of the references are listed.Increased risk of end-stage renal disease in patients with systemic sclerosis
C-Y Lin et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2022)
Implication of oxidative stress in the pathogenesis of systemic sclerosis via inflammation, autoimmunity and fibrosis
Ludivine Doridot et al.
REDOX BIOLOGY (2019)
Interleukin-17 pathways in systemic sclerosis-associated fibrosis
Sakir Ahmed et al.
RHEUMATOLOGY INTERNATIONAL (2019)
The Roles of IL-1 Family Cytokines in the Pathogenesis of Systemic Sclerosis
Dan Xu et al.
FRONTIERS IN IMMUNOLOGY (2019)
Citrullinated vimentin and biglycan protein fingerprints as candidate serological biomarkers for disease activity in systemic sclerosis: a pilot study
Anne Sofie Siebuhr et al.
BIOMARKERS (2019)
Endothelium structure and function in kidney health and disease
Noemie Jourde-Chiche et al.
NATURE REVIEWS NEPHROLOGY (2019)
Analysis of serum interleukin(IL)-1 alpha, IL-1 beta and IL-18 in patients with systemic sclerosis
Emily Lin et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2019)
Role of interleukin 17 in TGF-β signaling-mediated renal interstitial fibrosis
Bin Sun et al.
CYTOKINE (2018)
The Role of Oxidative Stress in the Development of Systemic Sclerosis Related Vasculopathy
Amaal E. Abdulle et al.
FRONTIERS IN PHYSIOLOGY (2018)
Complement C3 Produced by Macrophages Promotes Renal Fibrosis via IL-17A Secretion
Yanyan Liu et al.
FRONTIERS IN IMMUNOLOGY (2018)
Kidney involvement in systemic sclerosis: From pathogenesis to treatment
Cosimo Bruni et al.
JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2018)
Update of EULAR recommendations for the treatment of systemic sclerosis
Otylia Kowal-Bielecka et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Plasma and urinary glycosaminoglycans in the course of juvenile idiopathic arthritis
Katarzyna Winsz-Szczotka et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Alterations of plasma glycosaminoglycan profile in patients with rheumatoid arthritis in relation to disease activity
Agnieszka Jura-Poltorak et al.
CLINICA CHIMICA ACTA (2014)
Kidney involvement in systemic sclerosis
Virginia D. Steen
PRESSE MEDICALE (2014)
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative
Frank van den Hoogen et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Abnormal collagen V deposition in dermis correlates with skin thickening and disease activity in systemic sclerosis
Patricia Martin et al.
AUTOIMMUNITY REVIEWS (2012)
Evaluation of microalbuminuria in patients with systemic sclerosis as an indicator of early renal damage and increased morbidity
Somaya A. Hussien et al.
EGYPTIAN RHEUMATOLOGIST (2012)
Hyaluronan as an Immune Regulator in Human Diseases
Dianhua Jiang et al.
PHYSIOLOGICAL REVIEWS (2011)
The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosis
Laszló Czirjak et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Effects of interleukin 18 on injury and activation of human proximal tubular epithelial cells
Dong Liang et al.
NEPHROLOGY (2007)
Scleromyxedema-like lesions of patients in renal failure contain hyaluronan: a possible pathophysiological mechanism
BA Neudecker et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2005)
Aberrant serum hyaluronan and hyaluronidase levels in scleroderma
BA Neudecker et al.
BRITISH JOURNAL OF DERMATOLOGY (2004)
Enhanced expression of interleukin-18 and its receptor in idiopathic pulmonary fibrosis
Y Kitasato et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2004)
Pathophysiology of proteinuria
G D'Amico et al.
KIDNEY INTERNATIONAL (2003)
Share Paper
